Search results for: 'needs capture therapy'

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

28 Sep 2015  |  Asia Pacific  |  Market Research

End-User Perspectives on the SEA RIS/ PACS Market

Next-generation Imaging IT Needs Will Focus on Interoperability

Infographics

×

Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

Significant investment in health technology has helped improve the quality of healthcare services but has done little to reduce costs and make healthcare more accountable in the developed countries of Asia-Pacific. This insight explores future challenges that Japan and South Korea might face in terms of seamless healthcare integration.

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

A market outlook of the Cardiac Rhythm Management Devices covering China, Hong Kong, South Korea and Malaysia. This study includes the market drivers, restraints and forecasting for the pacemaker, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices and CRM leads. The forecast period of the study is from 2...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

This research deliverable provides deep insights into the clinical development and outsourcing market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the clinical trials registration process, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developmen...

24 Feb 2015  |  Asia Pacific  |  Market Research

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies

Infographics

×

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

This research deliverable provides detailed insights into the clinical development and outsourcing market of India. It also includes an overview of the Indian regulatory and R&D process briefing. It describes the Clinical trials scenario today at a therapeutic level of focus. Furthermore, it highlights the key trends, drivers, restraints and also t...